Article

PDF
Access to the PDF text
Advertising


Free Article !

Archives of cardiovascular diseases
Volume 102, n° S1
page 12 (mars 2009)
Doi : 10.1016/S1875-2136(09)72149-7
Themes et posters

A016 Association of PAI-1 4G/5G and -844G/A gene polymorphisms and changes in PAI-1/TPA levels in myocardial infarction. A casecontrol study
 

N. Abboud 1, L. Ghazouani 1, S. Saidi 1, S. Belhaj Khlifa 1, F. Addad 2, M. Mahjoub 2, Y.-W. Almawi 3, T. Mahjoub 1
1 Faculté de Pharmacie, Monastir, Tunisia 
2 Hôpital Universitaire Fattouma Bourguiba, Monastir, Tunisia 
3 Collège De Médecine et Sciences Médicales, Manama, Bahrain 

@@#100979@@
Background

Myocardial Infarction (MI) was reportedly precipitated by acquired and inherited risk factors including the G/A and 4G/5G polymorphisms within the promoter of the Plasminogen Activator Inhibitor -1 (PAI-1) gene.

Objective

to investigate the association between gene polymorphism of the PAI-1 and MI in Tunisian.

Methods

PAI-1 G/A was genotyped with polymerase chain reaction — restriction fragment length polymorphism (PCR-RFLP) while PAI-1 4G/5G promoter genotype was established by allele specific polymerase chain reaction amplification of genomic DNA. This study was performed in 305 myocardial infarction patients and 328 unrelated healthy controls. All subjects clinical features and PAI-1 and t-PA activity were tested.

Results

There were two polymorphisms within the promoter (a G/A single base substitution polymorphism at -844bp upstream from the start of transcription and an insertion (5G)/deletion (4G) polymorphism at position — 675). Higher frequency of the 4G allele (p<0.001; O.R.=1.929), but a lower frequency of the 5G allele (p<0.001; O.R.=0.356), were seen in patients vs. controls. The frequencies of the -844G (p<0.001; O.R.=0.314) allele was lower than -844A allele (p<0.001; O.R.=4.076) in patients versus controls. Furthermore significant elevation in plasma PAI-1 levels (88.43±52.85ng/ml vs. 62.18±39.31ng/ml; p <0.05) was seen among patients.

Conclusion

This study indicates that the risk of MI was notably high in 4G carriers and A carriers with elevated plasma PAI-1, and were associated with reduced t-PA levels.

The full text of this article is available in PDF format.
The full text of this article is available in PDF format.
Click here to see it.

Top of the page

© 2009  Elsevier Masson SAS. All Rights Reserved.
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Close
Article Outline
You can move this window by clicking on the headline
@@#110903@@